Perspective: Tominersen Testing Finds a Way Forward

J Huntingtons Dis. 2022;11(2):119-120. doi: 10.3233/JHD-229003.

Author

Neil Aronin^{1

2}

Affiliations

¹ Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
² RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA, USA.

PMID: 35599494
DOI: 10.3233/JHD-229003

No abstract available

Publication types

Editorial

MeSH terms

Humans
Huntington Disease*
Mass Screening
Oligonucleotides

Substances

Oligonucleotides
tominersen